Application of radiofrequency ablation for recurrent small hepatocellular carcinoma after hepatectomy
10.3781/j.issn.1000-7431.2017.55.297
- Author:
Zhuhui YUAN
1
Author Information
1. Center of Interventional Oncology and Liver Diseases, Beijing you'An Hospital, Capital Medical University
- Publication Type:Journal Article
- Keywords:
Hepatectomy;
Liver neoplasms;
Radiofrequency ablation;
Recurrent hepatocellular carcinoma
- From:
Tumor
2017;37(9):1001-1005
- CountryChina
- Language:Chinese
-
Abstract:
Hepatectomy is one of the curative therapies for hepatocellular carcinoma (HCC). However, the 5-year recurrence rate after resection is higher as 70%, and the 5-year survival rate is less than 50%. Furthermore, there is no consensus about the treatment strategy for recurrent HCC after hepatectomy. To our knowledge, radiofrequency ablation (RFA) has been widely applied, either with curative or palliative intention. And it is a feasible treatment for recurrent HCC because of majority of the recurrent HCCs with diameter less than 3 cm. The therapeutic efficacy after RFA is similar to re-resection with several advantages, such as minimal invasion, less complications and short hospitalization duration. This study discusses the feasibility of RFA which is used to treat recurrent small HCC, aiming at providing information for promoting the treatment efficacy of recurrent small HCC.
